semaglutide pka This flowchart depicts the downstream signaling pathways activated by Semaglutide phase 3 SUSTAIN trials

Always dispose of used needles in a proper sharps container

Patient-Centric Care At Level, patient well-being is at the forefront of every interaction

Adverse Reactions in Placebo-Controlled Trials Reported in 5% of Semaglutide Tablets-Treated Patients with Type 2 Diabetes Mellitus In the pool of placebo- and active-controlled trials, the types and frequency of common adverse reactions, excluding hypoglycemia, were similar to those listed in Table 2

These include certain antipsychotics (olanzapine, clozapine), mood stabilizers (valproate, lithium), antidepressants (mirtazapine, paroxetine), corticosteroids, and some diabetes medications like insulin or sulfonylureas